Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Pulmonary Drug Delivery: Market Overview
4.2 Geographic Analysis: Pulmonary Drug Delivery Market, By Application (2016)
4.3 Respiratory Drug Delivery Market, By Device Type (2016 vs 2021)
4.4 Pulmonary Nebulizers Market, By Type (2016–2021)
4.5 Geographic Snapshot: Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Preference for Pulmonary Drug Delivery as an Alternate Route of Drug Delivery
5.2.1.2 Increasing Focus on the Development of Smart/Digital Inhalers
5.2.1.3 Increasing Incidence of Respiratory Diseases
5.2.2 Market Restraints
5.2.2.1 Regulatory Issues
5.2.2.2 Pricing Pressure
5.2.3 Market Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Growth in Online Marketing Channels
5.2.4 Market Challenges
5.2.4.1 Issues With the Stability of Drugs
5.2.4.2 Deposition of Aerosolized Particles
6 Respiratory Drug Delivery Market, By Formulation
6.1 Introduction
6.2 Type
6.2.1 Suspension Aerosols
6.2.2 Solution Aerosols
6.2.3 Dry Powder Formulations
6.3 Device Type
6.3.1 Metered Dose Inhalers (MDIS)
6.3.2 Dry Powder Inhalers (DPIS)
6.3.3 Nebulizers
6.3.3.1 Jet Nebulizers
6.3.3.2 Ultrasonic Nebulizers
6.3.3.3 Soft Mist Nebulizers
7 Respiratory Drug Delivery Market, By Canister Type
7.1 Introduction
7.2 Plain Canisters
7.3 Coated Canister
8 Respiratory Drug Delivery Market, By Application
8.1 Introduction
8.2 Chronic Obstructive Pulmonary Disease
8.3 Asthma
8.4 Cystic Fibrosis
8.5 Other Applications
9 Respiratory Drug Delivery Market, By End User
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Home Care Settings
10 Respiratory Drug Delivery Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 Rest of Asia
10.5 Rest of the World
11 Competitive Landscape
11.1 Overview
11.2 Market Rank Analysis
11.3 Competitive Situations and Trends
11.3.1 Collaborations
11.3.2 Product Launches and Regulatory Approvals
11.3.3 Acquisitions
11.3.4 Expansions
12 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Introduction
12.2 Teva Pharmaceutical Industries Ltd.
12.3 3M
12.4 Glaxosmithkline PLC
12.5 Astrazeneca PLC
12.6 Boehringer Ingelheim
12.7 Merck & Co., Inc.
12.8 Novartis AG
12.9 Omron Corporation
12.10 Sunovion Pharmaceuticals Inc. (A Part of Sumitomo Dainippon Pharma Co., Ltd.)
12.11 Cipla Inc.
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.
13 Appendix
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details
List of Tables
Table 1 Companies Developing Smart/Digital Inhaler Technologies
Table 2 Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 3 Suspension Aerosols Market Size, By Region, 2014–2021 (USD Million)
Table 4 Solution Aerosols Market Size, By Region, 2014–2021 (USD Million)
Table 5 Dry Powder Formulations Market Size, By Region, 2014–2021 (USD Million)
Table 6 Pulmonary Drug Delivery Formulations Market Size, By Device Type , 2014–2021 (USD Million)
Table 7 Metered Dose Inhalers Market Size, By Region, 2014–2021 (USD Million)
Table 8 Dry Dose Inhalers Market Size, By Region, 2014–2021 (USD Million)
Table 9 Nebulizers Market Size, By Type, 2014–2021 (USD Million)
Table 10 Nebulizers Market Size, By Region, 2014–2021 (USD Million)
Table 11 Jet Nebulizers Market Size, By Region, 2014–2021 (USD Million)
Table 12 Ultrasonic Nebulizers Market Size, By Region, 2014–2021 (USD Million)
Table 13 Soft Mist Nebulizers Market Size, By Region, 2014–2021 (USD Million)
Table 14 Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 15 Plain Canisters Market Size, By Region, 2014–2021 (USD Million)
Table 16 Coated Canisters Market Size, By Region, 2014–2021 (USD Million)
Table 17 Pulmonary Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 18 Respiratory Drug Delivery Market Size for Copd, By Region, 2014–2021 (USD Million)
Table 19 Market Size for Asthma, By Region, 2014–2021 (USD Million)
Table 20 Market Size for Cystic Fibrosis, By Region, 2014–2021 (USD Million)
Table 21 Respiratory Drug Delivery Market Size for Other Applications, By Region, 2014–2021 (USD Million)
Table 22 Pulmonary Drug Delivery Market Size, By End User, 2014–2021 (USD Million)
Table 23 Market Size for Hospitals & Clinics, By Region, 2014–2021 (USD Million)
Table 24 Respiratory Drug Delivery Market Size for Home Care Settings, By Region, 2014–2021 (USD Million)
Table 25 Global Respiratory Drug Delivery Market Size, By Region, 2014–2021 (USD Million)
Table 26 North America: Respiratory Drug Delivery Market Size, By Country, 2014–2021 (USD Million)
Table 27 North America: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 28 North America: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 29 North America: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 30 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 31 North America: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 32 U.S.: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 33 U.S.: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 34 U.S.: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 35 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 36 U.S.: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 37 Canada: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 38 Canada: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 39 Canada: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 40 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 41 Canada: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 42 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 43 Europe: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 44 Europe: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 45 Europe: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 46 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 47 Europe: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 48 Germany: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 49 Germany: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 50 Germany: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 51 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 52 Germany: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 53 U.K.: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 54 U.K.: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 55 U.K.: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 56 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 57 U.K.: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 58 France: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 59 France: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 60 France: Respiratory Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 61 France: Market Size, By End User, 2014–2021 (USD Million)
Table 62 France: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 63 RoE: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 64 RoE: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 65 RoE: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 66 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 67 RoE: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 68 Asia: Respiratory Drug Delivery Market Size, By Country, 2014–2021 (USD Million)
Table 69 Asia: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 70 Asia: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 71 Asia: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 72 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 73 Asia: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 74 China: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 75 China: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 76 China: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 77 China: Market Size, By End User, 2014–2021 (USD Million)
Table 78 China: Market Size, By Application, 2014–2021 (USD Million)
Table 79 India: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 80 India: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 81 India: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 82 India: Market Size, By End User, 2014–2021 (USD Million)
Table 83 India: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 84 Japan: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 85 Japan: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 86 Japan: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 87 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 88 Japan: Market Size, By Application, 2014–2021 (USD Million)
Table 89 RoA: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 90 RoA: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 91 RoA: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 92 RoA: Market Size, By End User, 2014–2021 (USD Million)
Table 93 RoA: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 94 RoW: Pulmonary Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Million)
Table 95 RoW: Pulmonary Drug Delivery Formulations Market Size, By Device Type, 2014–2021 (USD Million)
Table 96 RoW: Pulmonary Drug Delivery Market Size, By Canister Type, 2014–2021 (USD Million)
Table 97 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 98 RoW: Respiratory Drug Delivery Market Size, By Application, 2014–2021 (USD Million)
Table 99 Market Ranking of the Key Players in the Respiratory Drug Delivery Market (2015)
Table 100 Collaborations, 2014–2016
Table 101 Product Launches and Regulatory Approvals, 2014–2016
Table 102 Acquisitions, 2014–2016
Table 103 Expansions, 2014–2016
Table 104 Exchange Rate (Utilized for the Conversion of Gbp to USD)
List of Figures
Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Global Pulmonary Drug Delivery Market Size, By Device Type, 2016 vs 2021
Figure 7 Global Market Size, By Application, 2016 vs 2021
Figure 8 Global Pulmonary Drug Delivery Market Size, By Canister Type, 2016 vs 2021
Figure 9 Global Respiratory Drug Delivery Market Size, By End User, 2016 vs 2021
Figure 10 Geographical Snapshot of the Market
Figure 11 Increasing Incidence of Respiratory Diseases is A Key Market Driver for Pulmonary Drug Delivery
Figure 12 Asthma Forms the Largest Application Segment in the Pulmonary Drug Delivery Market
Figure 13 Metered-Dose Inhalers to Command the Largest Market Share in 2016
Figure 14 Jet Nebulizers to Dominate the Pulmonary Nebulizers Market in 2016
Figure 15 China to Register Highest Growth Rate During the Forecast Period
Figure 16 Respiratory Drug Delivery Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 U.K.: Estimated Number of People Diagnosed With Asthma (2004–2012)
Figure 18 North America: Pulmonary Drug Delivery Market Snapshot
Figure 19 Europe: Market Snapshot
Figure 20 Asia: Respiratory Drug Delivery Market Snapshot
Figure 21 Key Developments in the Pulmonary Drug Delivery Market, 2014–2016
Figure 22 Battle for Market Share: Collaborations Accounted for the Largest Share of the Total Developments During 2014 to 2016
Figure 23 Geographic Revenue Mix for the Top 5 Players in the Market
Figure 24 Teva Pharmaceutical Industries Ltd.: Company Snapshot (2015)
Figure 25 3M: Company Snapshot (2015)
Figure 26 Glaxosmithkline PLC: Company Snapshot (2015)
Figure 27 Astrazeneca PLC: Company Snapshot (2015)
Figure 28 Boehringer Ingelheim: Company Snapshot (2015)
Figure 29 Merck & Co., Inc.: Company Snapshot (2015)
Figure 30 Novartis AG: Company Snapshot (2015)
Figure 31 Omron Corporation: Company Snapshot (2015)
Figure 32 Sumitomo Dainippon Pharma Co., Ltd.: Company Snapshot (2015)
Figure 33 Cipla Inc.: Company Snapshot (2016)